**Core Concept:** Chronic Hepatitis B infection is a viral infection caused by the Hepatitis B virus (HBV) that can lead to liver cirrhosis and hepatocellular carcinoma. The markers used to assess disease activity and transmission risk include serum hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and hepatitis B e antibody (HBeAb).

**Why the Correct Answer is Right:** The correct answer is D, which refers to Hepatitis B e antigen (HBeAg). HBeAg is a marker indicative of active viral replication within the liver cells (hepatocytes) of a patient with chronic HBV infection. This means that HBeAg-positive individuals are more likely to transmit the virus to others. The presence of HBeAg in the serum indicates a high viral load and increased risk of disease transmission.

**Why Each Wrong Option is Incorrect:**

A. Hepatitis B surface antigen (HBsAg): HBsAg is present in chronic HBV carriers and indicates the presence of the virus in the bloodstream. However, it does not specifically indicate active viral replication or transmission risk.

B. Hepatitis B core antibody (anti-HBc): Anti-HBc is an antibody produced in response to HBV infection. It does not indicate viral replication or transmission risk.

C. Hepatitis B e antibody (HBeAb): HBeAb is an antibody against HBeAg, not a marker of viral replication or transmission risk.

**Clinical Pearl:** In clinical practice, measuring HBeAg status can help guide decisions regarding antiviral therapy and transmission risk assessment for patients and their contacts. A negative HBeAg (HBeAb) indicates low viral replication and lower transmission risk. On the other hand, a positive HBeAg indicates high viral replication and increased transmission risk.